QuickRead System: CRP Kit Model 06085; QuickRead 101 Instrument Model 06088; CRP Control Set
510(k) K042442
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK042442 | Date24 Sep 2004 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Full name
- Quickread System: Quickread Crp Kit, Model 06085; Quickread 101 Instrument, Model 06088; Quickread Crp Control Set, Mode
- 510(k) Number
- FDA Product Code
- DCK
- Device Class
- Class II
- Regulation
- 21 CFR Part 866.5270
- Advisory Committee
- Immunology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 19 Sep 2026
The QuickRead System is a diagnostic device for the quantitative measurement of C-reactive protein (CRP) in whole blood or plasma. CRP is an acute-phase protein used as a biomarker to assess inflammatory responses, aiding in the evaluation of infectious or non-infectious inflammatory conditions.
The system consists of a CRP Kit (Model 06085), a QuickRead 101 Instrument (Model 06088), and a CRP Control Set. It is intended for single-use in clinical laboratory settings and has received FDA 510(k) clearance under Special Review (SESE) in the Immunology category. The device is classified as Class II and regulated under 21 CFR 866.5270.
Other devices from Orion Diagnostica, Inc.
Questions
AI-generated answers, 19 Sep 2026
What clinical conditions can the QuickRead CRP Kit help evaluate using C-reactive protein levels as a biomarker?
The QuickRead System measures C-reactive protein (CRP) in whole blood or plasma to assess inflammatory responses. CRP is used as a biomarker to evaluate both infectious and non-infectious inflammatory conditions, such as infections, autoimmune diseases, or other systemic inflammatory processes. It aids clinicians in monitoring disease activity or response to treatment in conditions where inflammation plays a key role.
Is the QuickRead CRP Kit designed for single-use or repeated use in a clinical setting?
The QuickRead CRP Kit (Model 06085) is explicitly intended for single-use in clinical laboratory settings. This design ensures patient safety and consistency in test results, as reuse could compromise sterility or accuracy. The accompanying QuickRead 101 Instrument (Model 06088) is also intended for use with single-use kits.
How is the QuickRead System supplied, and what components are included in the full kit?
The QuickRead System consists of three main components: the QuickRead CRP Kit (Model 06085), the QuickRead 101 Instrument (Model 06088), and the QuickRead CRP Control Set. These components work together to perform quantitative CRP measurements in whole blood or plasma. The kit is designed for use in clinical laboratories, where the instrument reads results from the single-use CRP test strips included in the kit.
What regulatory pathway was followed for FDA clearance of the QuickRead System, and what category does it fall under?
The QuickRead System received FDA 510(k) clearance under Special Review (SESE) in the Immunology category. This classification aligns with its use for measuring CRP, a key biomarker in inflammatory and immune-related evaluations. The device is classified as Class II and regulated under 21 CFR 866.5270, reflecting its role in diagnostic testing for clinical decision-making.